What is Dianthus Therapeutics's investment & other income?

Dianthus Therapeutics (DNTH) reported investment & other income of $6.27M in Q1 2026.

How has Dianthus Therapeutics's investment & other income changed year-over-year?

Dianthus Therapeutics's investment & other income increased by 65.3% year-over-year, from $3.79M to $6.27M.

Dianthus Therapeutics DNTH Investment & Other Income

Investment & Other Income at other companies

ESN

Essent GroupESNT

$60.83M+1.5%

Lincoln NationalLNC

$130.5M+69.5%

Blackstone Secured Lending FundBXSL

$325.47M-9.0%

BlackstoneBX

$107.94M+10.8%

Blue Owl CapitalOBDC

$396.77M-14.6%

Main Street CapitalMAIN

$140.11M+2.2%

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterestAndDividend.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's investment & other income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's investment & other income?: Dianthus Therapeutics (DNTH) reported investment & other income of $6.27M in Q1 2026.
How has Dianthus Therapeutics's investment & other income changed year-over-year?: Dianthus Therapeutics's investment & other income increased by 65.3% year-over-year, from $3.79M to $6.27M.